Pediatrix Medical Group Inc (NYSE: MD) has experienced a decline in its stock price by -3.84% compared to its previous closing price of $14.33. However, the company has seen a gain of 1.10% in its stock price over the last five trading days. businesswire.com reported 2025-07-01 that FORT LAUDERDALE, Fla.–(BUSINESS WIRE)—- $MD–Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director.
Is It Worth Investing in Pediatrix Medical Group Inc (NYSE: MD) Right Now?
The 36-month beta value for MD is also noteworthy at 1.22. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 5 rating it as “hold,” and 0 rating it as “sell.”
The public float for MD is 84.40M, and at present, short sellers hold a 2.58% of that float. The average trading volume of MD on July 03, 2025 was 875.52K shares.
MD’s Market Performance
The stock of Pediatrix Medical Group Inc (MD) has seen a 1.10% increase in the past week, with a 1.77% rise in the past month, and a -5.03% fall in the past quarter. The volatility ratio for the week is 3.70%, and the volatility levels for the past 30 days are at 3.04% for MD. The simple moving average for the past 20 days is -0.52% for MD’s stock, with a 0.42% simple moving average for the past 200 days.
Analysts’ Opinion of MD
Jefferies, on the other hand, stated in their research note that they expect to see MD reach a price target of $14, previously predicting the price at $8. The rating they have provided for MD stocks is “Buy” according to the report published on September 26th, 2024.
Deutsche Bank gave a rating of “Hold” to MD, setting the target price at $8 in the report published on June 07th of the previous year.
MD Trading at -0.03% from the 50-Day Moving Average
After a stumble in the market that brought MD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.01% of loss for the given period.
Insider Trading
ORDAN MARK S, the Director of Pediatrix Medical Group Inc, sale 27,600 shares at $15.35 during a trade that took place back on Nov 13 ’24, which means that ORDAN MARK S is holding 138,683 shares at $423,660 based on the most recent closing price.
Stock Fundamentals for MD
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.23 for the gross margin
The net margin for Pediatrix Medical Group Inc stands at -0.04. The total capital return value is set at 0.09. Equity return is now at value -10.01, with -3.96 for asset returns.
Based on Pediatrix Medical Group Inc (MD), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at 0.34. The debt to equity ratio resting at 0.83. The interest coverage ratio of the stock is 3.92.
Currently, EBITDA for the company is -28.37 million with net debt to EBITDA at -11.7. When we switch over and look at the enterprise to sales, we see a ratio of 0.88. The receivables turnover for the company is 7.82for trailing twelve months and the total asset turnover is 0.99. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.81.
Conclusion
In summary, Pediatrix Medical Group Inc (MD) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
